Biologic aging results in a chronic inflammatory condition, termed inflammaging, which establishes a risk for such age-related diseases as neurocardiovascular diseases; therefore, it is of great importance to develop rejuvenation strategies that are able to attenuate inflammaging as ameans of intervention for age-relateddiseases.A promising rejuvenation factor that is present in young blood has been found that canmake aged neurons younger; however, the component in the young blood and its mechanism of action are poorly elucidated. We assessed rejuvenation in naturally aged mice with extracellular vesicles (EVs) or exosomes extracted from young murine serum on the basis of different spectrums of microRNAs in these vesicles from young and old sera.We found that EVs extracted from young donor mouse serum, rather than EVs extracted from old donor mouse serum or non-EV supernatant extracted from young donor mouse serum, were able to attenuate inflammaging in old mice. Inflammaging is attributed to multiple factors, one of which is thymic aging-released self-reactive T cell-induced pathology. We found that the attenuation of inflammaging after treatment with EVs from young serum partially contributed to the rejuvenation of thymic aging, which is characterized by partially reversed thymic involution, enhancementofnegative selectionsignals,andreducedautoreactions intheperiphery.Our resultsprovide evidence for understanding of the potential rejuvenation factor in the young donor serum,which holds great promise for the development of novel therapeutics to reduce morbidity and mortality caused by age-related inflammatory diseases.
- Age-related thymic involution
- Chronic inflammation
- Young serum